应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVS 诺华
未开盘 07-19 16:00:00 EDT
106.13
-1.09
-1.02%
盘后
107.00
+0.87
+0.82%
19:38 EDT
最高
106.53
最低
105.72
成交量
168.33万
今开
106.35
昨收
107.22
日振幅
0.76%
总市值
2,165亿
流通市值
2,069亿
总股本
20.40亿
成交额
1.79亿
换手率
0.09%
流通股本
19.49亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
诺华制药2024财年第二财季实现净利润32.46亿美元,同比增加40.16%
自选股智能写手 · 07-19 22:03
诺华制药2024财年第二财季实现净利润32.46亿美元,同比增加40.16%
标普500指数扩大跌幅,日内下跌1%。医药板块领跌,礼来(LLY)跌6.2%,诺华(NVS)与雅培(ABT)各跌逾4%
华尔街见闻 · 07-19
标普500指数扩大跌幅,日内下跌1%。医药板块领跌,礼来(LLY)跌6.2%,诺华(NVS)与雅培(ABT)各跌逾4%
盘前异动|台积电强劲业绩带飞半导体板块!一餐饮股暴涨近50%
老虎资讯综合 · 07-18
盘前异动|台积电强劲业绩带飞半导体板块!一餐饮股暴涨近50%
处方药Entresto和Kesimpta销量超预期 诺华制药(NVS.US)再次上调全年盈利指引
智通财经网 · 07-18
处方药Entresto和Kesimpta销量超预期 诺华制药(NVS.US)再次上调全年盈利指引
Novartis(NVS.US):2024年Q2财报实现营收125.12亿美元,前值为114.37亿
智通财经 · 07-18
Novartis(NVS.US):2024年Q2财报实现营收125.12亿美元,前值为114.37亿
诺华Q2销售净额125.1亿美元,超市场预期
老虎资讯综合 · 07-18
诺华Q2销售净额125.1亿美元,超市场预期
21健讯Daily|安徽将辅助生殖纳入医保;天境生物、诺华中国管理层变动
21财经网 · 07-17
21健讯Daily|安徽将辅助生殖纳入医保;天境生物、诺华中国管理层变动
TIGIT靶点命途多舛!罗氏再受挫,诺华、默沙东刹车,吉利德、GSK前景几何?
医药经济报 · 07-12
TIGIT靶点命途多舛!罗氏再受挫,诺华、默沙东刹车,吉利德、GSK前景几何?
MorphoSys任命诺华高管为新任CEO和CFO
财通社 · 06-07
MorphoSys任命诺华高管为新任CEO和CFO
诺华白血病药物在试验中比旧版疗法更有效
Reuters · 05-31
诺华白血病药物在试验中比旧版疗法更有效
Arvinas-由于Hsr终止并满足了许可协议、资产协议的成交条件诺华制药股份公司将向公司支付1.5亿美元
智通财经 · 05-31
Arvinas-由于Hsr终止并满足了许可协议、资产协议的成交条件诺华制药股份公司将向公司支付1.5亿美元
诺华制药涨1.03% 股价突破100美元大关
自选股智能写手 · 05-30
诺华制药涨1.03% 股价突破100美元大关
诺华制药跌0.55% 股价跌破100美元大关
自选股智能写手 · 05-28
诺华制药跌0.55% 股价跌破100美元大关
诺华将更换中国区总裁:张颖赴总部任职,日本总裁接任
经济观察报 · 05-14
诺华将更换中国区总裁:张颖赴总部任职,日本总裁接任
诺华中国区换帅 新任中国区总裁将于6月到任
环球网 · 05-14
诺华中国区换帅 新任中国区总裁将于6月到任
更新版 1-由于需求稳定、价格上涨,Pop-Tarts 制造商凯兰诺华业绩超出预期
Reuters · 05-02
更新版 1-由于需求稳定、价格上涨,Pop-Tarts 制造商凯兰诺华业绩超出预期
受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行
智通财经 · 04-29
受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行
诺华制药2024财年第一财季实现净利润26.88亿美元,同比增加17.23%
自选股智能写手 · 04-25
诺华制药2024财年第一财季实现净利润26.88亿美元,同比增加17.23%
隔夜美股全复盘(4.24)| 三大股指集体高收,英伟达涨近4%;特斯拉营收遇滑铁卢,意外宣布力推平价车型助推股价盘后一度涨逾11%
格隆汇 · 04-24
隔夜美股全复盘(4.24)| 三大股指集体高收,英伟达涨近4%;特斯拉营收遇滑铁卢,意外宣布力推平价车型助推股价盘后一度涨逾11%
欧股“十一罗汉”|AI云概念股SAP收涨将近5.3%,阿斯麦控股涨2.6%,诺和诺德与诺华涨超1.8%
智通财经 · 04-24
欧股“十一罗汉”|AI云概念股SAP收涨将近5.3%,阿斯麦控股涨2.6%,诺和诺德与诺华涨超1.8%
加载更多
公司概况
公司名称:
诺华
所属市场:
NYSE
上市日期:
--
主营业务:
Novartis AG于1996年2月29日在瑞士成立。该公司提供满足全球患者和社会不断变化的需求的医疗保健解决方案。他们广泛的产品组合包括创新药物和肿瘤药物,仿制药和生物仿制药以及眼科护理设备。他们的使命是发现改善和延伸人们生活的新方法。他们的愿景是成为改变医学实践的值得信赖的领导者。他们的战略是利用科学的创新在不断增长的医疗领域提供更好的患者结果。
发行价格:
--
{"stockData":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"诺华","latestPrice":106.13,"timestamp":1721419200000,"preClose":107.22,"halted":0,"volume":1683292,"hourTrading":{"tag":"盘后","latestPrice":107,"preClose":106.13,"latestTime":"19:38 EDT","volume":14734,"amount":1563806.1901,"timestamp":1721432307636},"delay":0,"floatShares":1949080245,"shares":2040406387,"eps":7.354219,"marketStatus":"未开盘","marketStatusCode":0,"change":-1.09,"latestTime":"07-19 16:00:00 EDT","open":106.35,"high":106.53,"low":105.72,"amount":178679695.17632002,"amplitude":0.007555,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.354219,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721635200000},"adr":1,"adjPreClose":107.22,"adrRate":1,"dividendRate":0.036926,"preHourTrading":{"tag":"盘前","latestPrice":106.33,"preClose":107.22,"latestTime":"09:29 EDT","volume":13192,"amount":1406714.857328,"timestamp":1721395799999},"postHourTrading":{"tag":"盘后","latestPrice":107,"preClose":106.13,"latestTime":"19:38 EDT","volume":14734,"amount":1563806.1901,"timestamp":1721432307636},"volumeRatio":0.8992012652607085,"impliedVol":0.2172,"impliedVolPercentile":0.7103},"requestUrl":"/m/hq/s/NVS","defaultTab":"news","newsList":[{"id":"2452647453","title":"诺华制药2024财年第二财季实现净利润32.46亿美元,同比增加40.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452647453","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452647453?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:03","pubTimestamp":1721397833,"startTime":"0","endTime":"0","summary":"7月19日,诺华制药公布财报,公告显示公司2024财年第二财季净利润为32.46亿美元,同比增加40.16%;其中营业收入为125.12亿美元,同比减少8.15%,每股基本收益为1.60美元。从资产负债表来看,诺华制药总负债556.03亿美元,其中短期债务77.64亿美元,资产负债比为1.76,流动比率为0.94。机构评级:截至2024年7月19日,当前有21家机构对诺华制药目标价做出预测,其中目标均价为115.63美元,其中最低目标价为86.02美元,最高目标价为139.51美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192203599f6c14fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192203599f6c14fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVS"],"gpt_icon":0},{"id":"2452453285","title":"标普500指数扩大跌幅,日内下跌1%。医药板块领跌,礼来(LLY)跌6.2%,诺华(NVS)与雅培(ABT)各跌逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452453285","media":"华尔街见闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452453285?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:58","pubTimestamp":1721329084,"startTime":"0","endTime":"0","summary":"更多消息,持续更新中","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/d0/24/94/-1-2-.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/d0/24/94/-1-2-.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3720109","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3720109","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["OEX","ABT","LU0640476718.USD","SPXU","BK4534","BK4082","LU0456855351.SGD","BK4588","LU0234572021.USD","LU0266013472.USD","LU0320765059.SGD","LU0256863902.USD","LU1064131342.USD","09939","BK1574","BK4581","IE00BK4W5L77.USD","SDS","SH","IE00BK4W5M84.HKD","LLY","UPRO","LU0238689110.USD","LU0471298777.SGD","LU1057294990.SGD","BK4532","LU0289739699.SGD","NVS","LU2468319806.SGD","BK4504","IE00B4R5TH58.HKD","LU0094547139.USD",".SPX","SPY","LU2237957811.SGD","BK4592","OEF","SGXZ23171101.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU0417517546.SGD","SG9999004303.SGD","SSO","ESmain","LU0198837287.USD","LU1267930730.SGD","IVV","LU2237957902.USD","SG9999002224.SGD","LU0672654240.SGD"],"gpt_icon":1},{"id":"1182606189","title":"盘前异动|台积电强劲业绩带飞半导体板块!一餐饮股暴涨近50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182606189","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1182606189?lang=zh_cn&edition=full","pubTime":"2024-07-18 16:02","pubTimestamp":1721289750,"startTime":"0","endTime":"0","summary":"美股半导体板块盘前集体走高,$台积电$绩后涨近4%,$英伟达$、$美光科技$、$超微电脑$、AMD、ARM涨超2%;Beyond Meat盘前大跌逾14%,消息称其与债券持有人洽重组债务;$诺华$盘前跌近2%,公司前列腺癌药物Pluvicto销售失误引发增长担忧;$诺基亚$盘前跌超7%,Q2销售净额44.7亿欧元,不及市场预期;Chuy's Holdings盘前暴涨近50%,Darden Restaurants将以6.05亿美元收购。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837565.USD","BK4141","LU0488056044.USD","AMD","ASML","NOK","BK4503","LU1282649810.SGD","BK4505","SG9999004220.SGD","NVS","LU2125154935.USD","TSM","LU0572939691.SGD","LU1282649067.USD","CHUY","LU1267930813.SGD","LU0384037296.USD","BK4512","LU0143863198.USD","BK4581","BYND","LU0878005551.USD","NVDA"],"gpt_icon":0},{"id":"2452478179","title":"处方药Entresto和Kesimpta销量超预期 诺华制药(NVS.US)再次上调全年盈利指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2452478179","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452478179?lang=zh_cn&edition=full","pubTime":"2024-07-18 16:00","pubTimestamp":1721289600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,得益于治疗心力衰竭的药物 Entresto 和治疗多发性硬化症的药物 Kesimpta 在内的药物处方量增加,诺华制药公布了好于预期的第二季度业绩,并且第二次上调了 2024 年盈利预期。财报显示,该公司Entresto、用于治疗多发性硬化症的 Kesimpta 以及获得新用途批准的抗炎药物 Cosentyx 的销售额均超出了市场预期。该集团已进行了裁员,并剥离了仿制药业务山德士,尽管其畅销药物 Entresto 和用于治疗血小板缺乏症的 Promacta 明年将失去美国专利保护,但集团仍确认了中期增长目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816070795d41e3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816070795d41e3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4532","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0211331839.USD","NVS","BK4007","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4578","IE0009355771.USD","BK4585"],"gpt_icon":0},{"id":"2452655124","title":"Novartis(NVS.US):2024年Q2财报实现营收125.12亿美元,前值为114.37亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2452655124","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452655124?lang=zh_cn&edition=full","pubTime":"2024-07-18 13:28","pubTimestamp":1721280536,"startTime":"0","endTime":"0","summary":"Novartis(NVS.US):2024年Q2财报实现营收125.12亿美元,前值为114.37亿美元,预期值为122.8亿美元;每股收益为1.97美元,前值为1.8美元,预期值为1.86美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181337119f61f7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407181337119f61f7eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVS"],"gpt_icon":0},{"id":"1117612157","title":"诺华Q2销售净额125.1亿美元,超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1117612157","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1117612157?lang=zh_cn&edition=full","pubTime":"2024-07-18 13:10","pubTimestamp":1721279447,"startTime":"0","endTime":"0","summary":"7月18日,$诺华(NVS)$第二季度销售净额125.1亿美元,预估122.8亿美元;核心每股收益1.97美元,预估1.87美元。财报发布后,诺华美股夜盘直线拉升,现涨近2%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b81c6f5a81a4ccb9da22b56116526b9","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺华Q2销售净额125.1亿美元,超市场预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IE0002141913.USD","IE0009355771.USD","BK4585","IE00BFTCPJ56.SGD","NVS","BK4578","BK4007","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0211331839.USD","IE00B2B36J28.USD","BK4588"],"gpt_icon":0},{"id":"2452212922","title":"21健讯Daily|安徽将辅助生殖纳入医保;天境生物、诺华中国管理层变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2452212922","media":"21财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452212922?lang=zh_cn&edition=full","pubTime":"2024-07-17 07:45","pubTimestamp":1721173533,"startTime":"0","endTime":"0","summary":"政策动向安徽、河北将辅助生殖纳入医保7月16日,国家医保局官方微信发文称,自8月1日起,辅助生殖将被纳入安徽医保报销范围,部分治疗性辅助生殖类医疗服务项目被纳入河北医保。该药物由美国Marinus公司研发,并由元羿生物于2022年授权引进中国。诺华中国管理团队变化7月16日,诺华宣布现中国肿瘤领域治疗负责人严琼即将离任,这一岗位由现任零售、新兴市场及商务部负责人陈晖暂代。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170745379f5982d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170745379f5982d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE0002141913.USD","BK4007","BK4588","BK4532","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4585","NVS","BK4578","IE0009355771.USD","IMAB","BK4526","BK4505","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4535"],"gpt_icon":0},{"id":"2450854285","title":"TIGIT靶点命途多舛!罗氏再受挫,诺华、默沙东刹车,吉利德、GSK前景几何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2450854285","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450854285?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:56","pubTimestamp":1720781795,"startTime":"0","endTime":"0","summary":"作为肿瘤治疗领域的潜力靶点,TIGIT靶点药物命途多舛的研发进程,产业始终给予高度关注。这是全球首个TIGIT III期临床失败案例。2021年底,TIGIT靶点迎来商业合作热潮。短短一个月内,3个重大的制药行业合作案例将TIGIT靶点推向了前所未有的热度。然而,随着临床试验的深入,TIGIT靶点药物的实际疗效和安全性受到更严格的检验。尽管如此,罗氏并未完全放弃对TIGIT靶点的探索。诺华、默沙东“撤退”吉利德、GSK前景几何?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121903089f3b5288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121903089f3b5288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023059063.AUD","BK4533","IE00BJT1NW94.SGD","LU1839511570.USD","BK4583","LU1037948541.HKD","LU1057294990.SGD","LU1061106388.HKD","LU1934455863.HKD","LU0320765992.SGD","IE00BLSP4239.USD","BK4007","BK4566","LU1989772840.SGD","BK4578","LU1571399168.USD","LU1066053197.SGD","BK4550","LU2468319806.SGD","LU1066051225.USD","IE00B1BXHZ80.USD","GSK.UK","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4585","LU0058720904.USD","MRK","IE000M9KFDE8.USD","BK4588","LU0289739699.SGD","LU1066051498.USD","IE0002141913.USD","LU1585245621.USD","BK4568","LU1066051811.HKD","BK4534","BK4139","LU1093756168.USD","BK4516","IE00BBT3K403.USD","GILD","BK4559","LU0208291251.USD","LU0265550359.USD","LU1989771016.USD","NVS","GSK","LU0965509283.SGD","LU0122379950.USD"],"gpt_icon":0},{"id":"2441838777","title":"MorphoSys任命诺华高管为新任CEO和CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2441838777","media":"财通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441838777?lang=zh_cn&edition=full","pubTime":"2024-06-07 08:25","pubTimestamp":1717719900,"startTime":"0","endTime":"0","summary":"生物制药公司MorphoSys当地时间6月6日公告称,决定任命ArkadiusPichota为新任首席执行官,Pichota是诺华子公司NavigateBioPharmaServices的总裁;决定任命LukasGilgen为新任首席财务官,Gilgen是诺华公司企业项目的交易负责人。此前在2月,诺华制药宣布将以27亿欧元收购总部位于德国的生物制药公司MorphoSys,将MorphoSys的癌症治疗药物纳入其产品线。(界面)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406070826089f2232aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406070826089f2232aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVS","BK4139","IE00BJJMRZ35.SGD","BK4588","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","MOR","IE0009355771.USD","BK4532","BK4007","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0211331839.USD","BK4578"],"gpt_icon":0},{"id":"2439998792","title":"诺华白血病药物在试验中比旧版疗法更有效","url":"https://stock-news.laohu8.com/highlight/detail?id=2439998792","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439998792?lang=zh_cn&edition=full","pubTime":"2024-05-31 20:00","pubTimestamp":1717156804,"startTime":"0","endTime":"0","summary":"虽然旧的TKIs彻底改变了CML的治疗,但许多患者最终症状复发或因副作用而无法继续治疗。在试验期间,仅有5%的Scemblix患者因不良副作用而中断治疗,而接受任何一种TKIs治疗的患者的辍治率为10%,TKIs可导致疲劳、抑郁、睡眠紊乱、腹泻和其他副作用。该试验仍在进行中,下一次计划在第96周进行分析,以进一步评估MMR和停药率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1670711123.USD","BK4559","BK4568","LU0122379950.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","NVS","IE00BJT1NW94.SGD","IE00BBT3K403.USD","BK4532","IE00BJJMRZ35.SGD","SG9999001176.SGD","LU0321505439.SGD","LU0321505868.SGD","BMY","SG9999003800.SGD","LU1261432733.SGD","LU1066051498.USD","LU0211331839.USD","LU0061475181.USD","IE0002141913.USD","LU0289739699.SGD","LU0868494617.USD","IE00B19Z3B42.SGD","LU1074936037.SGD","IE00BLSP4239.USD","LU1571399168.USD","BK4533","SG9999001176.USD","LU1023059063.AUD","LU1989771016.USD","IE0002270589.USD","PFE","BK4585","LU2242652126.USD","SGXZ57979304.SGD","LU1057294990.SGD","IE0009355771.USD","LU0237698245.USD","BK4550","LU0114720955.EUR","SG9999011175.SGD","LU1670710661.SGD","BK4007","LU1670710588.SGD","LU0882574055.USD","LU0058720904.USD","LU0170899867.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2439580605","title":"Arvinas-由于Hsr终止并满足了许可协议、资产协议的成交条件诺华制药股份公司将向公司支付1.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439580605","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439580605?lang=zh_cn&edition=full","pubTime":"2024-05-31 05:06","pubTimestamp":1717103219,"startTime":"0","endTime":"0","summary":"Arvinas-由于Hsr终止并满足了许可协议、资产协议的成交条件诺华制药股份公司将向公司支付1.5亿美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310507019f072b2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310507019f072b2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVS","IE00BJJMRZ35.SGD","BK4588","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","IE0009355771.USD","BK4532","BK4007","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0211331839.USD","BK4578"],"gpt_icon":0},{"id":"2439264701","title":"诺华制药涨1.03% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2439264701","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439264701?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:31","pubTimestamp":1717075907,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时31分,诺华制药股票出现异动,股价急速拉升1.03%。截至发稿,该股报100.39美元/股,成交量3.5855万股,换手率0.00%,振幅0.11%。诺华制药股票所在的制药行业中,整体涨幅为0.21%。其相关个股中,祁连国际、Canopy Growth Corporation、Petros Pharmaceuticals, Inc.涨幅较大,Sonoma Pharmaceuticals, Inc.、Akanda Corp.、苏轩堂较为活跃,换手率分别为6.73%、3.57%、3.18%,振幅较大的相关个股有Lucy Scientific Discovery Inc.、Akanda Corp.、Canopy Growth Corporation,振幅分别为8.07%、4.68%、4.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302131479f058e35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302131479f058e35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","BK4007","BK4588","BK4532","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4585","NVS","BK4578","IE0009355771.USD","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2438937206","title":"诺华制药跌0.55% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2438937206","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438937206?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:39","pubTimestamp":1716903552,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时39分,诺华制药股票出现波动,股价快速下跌0.55%。截至发稿,该股报99.98美元/股,成交量3.5226万股,换手率0.00%,振幅0.28%。诺华制药股票所在的制药行业中,整体跌幅为0.43%。其相关个股中,大自然药业、Alimera Sciences, Inc.、Fsd Pharma Inc.涨幅较大,Akanda Corp.、苏轩堂、Lucy Scientific Discovery Inc.较为活跃,换手率分别为19.24%、1.84%、1.41%,振幅较大的相关个股有Lucy Scientific Discovery Inc.、大自然药业、Biofrontera Inc.,振幅分别为18.16%、12.08%、11.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213913968103d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213913968103d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE0009355771.USD","IE0002141913.USD","BK4532","BK4585","IE00BFTCPJ56.SGD","NVS","BK4007","IE00BJJMRZ35.SGD","BK4578","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0211331839.USD"],"gpt_icon":0},{"id":"2435559240","title":"诺华将更换中国区总裁:张颖赴总部任职,日本总裁接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2435559240","media":"经济观察报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435559240?lang=zh_cn&edition=full","pubTime":"2024-05-14 13:39","pubTimestamp":1715665171,"startTime":"0","endTime":"0","summary":"经济观察网 记者 瞿依贤 经济观察网获悉,5月13日,诺华国际业务部总裁赫博瑞宣布,现任诺华中国区总裁张颖将从6月1日起担任诺华国际业务部首席商务官(CCO),领导诺华商业上市战略团队,常驻巴塞尔;现任诺华日本总裁Leo Lee将被任命为中国区总裁。诺华中国区一位员工向经济观察网表示,张颖在5月13日通过内部邮件向中国...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OG_cuTcKLKqwqRg--67kRgw56AGP4Qwh6_7oUYwiMQONkAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OG_cuTcKLKqwqRg--67kRgw56AGP4Qwh6_7oUYwiMQONkAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240514A04PFV00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240514A04PFV00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["IE00BJJMRZ35.SGD","BK4578","IE00BJT1NW94.SGD","IE0009355771.USD","LU0211331839.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4532","BK4585","NVS","BK4588","BK4007"],"gpt_icon":0},{"id":"2435534933","title":"诺华中国区换帅 新任中国区总裁将于6月到任","url":"https://stock-news.laohu8.com/highlight/detail?id=2435534933","media":"环球网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435534933?lang=zh_cn&edition=full","pubTime":"2024-05-14 10:33","pubTimestamp":1715654025,"startTime":"0","endTime":"0","summary":"5月14日消息,诺华国际业务部总裁赫博瑞发布内部信,向员工宣布了一系列人事变动。根据信息,自 6 月 1 日起,现诺华中国区总裁张颖被任命为诺华国际业务部首席商务官,领导诺华商业上市战略团队,常驻巴塞尔。现任诺华日本总裁 Leo Lee 被任命为中国区总裁。对此,诺华内部人士表示,该消息属实。2022年4月22日,张颖被任命为创新药物中国总裁兼董事总经理。2023年10月1日,张颖接任诺华集团中国总裁一职。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.huanqiu.com/article/4HmopZesfTl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huanqiu","symbols":["BK4585","LU0211331839.USD","IE0009355771.USD","IE00B2B36J28.USD","BK4532","BK4007","NVS","BK4578","IE00BJT1NW94.SGD","IE0002141913.USD","BK4588","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2432602247","title":"更新版 1-由于需求稳定、价格上涨,Pop-Tarts 制造商凯兰诺华业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432602247","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432602247?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:08","pubTimestamp":1714658900,"startTime":"0","endTime":"0","summary":"Kellanova公司的产品组合多样化,包括Grahams饼干、Nutri-Grain早餐棒和Morningstar Farms等冷冻食品,加上溢价定价,帮助减轻了一些消费者转向低价替代品的影响。该公司表示,本季度价格上涨了 8.5%,而有机食品的销量却下降了 3.1%。该公司还拥有 Frosties 和 Special K 等国际知名麦片品牌,本季度调整后每股利润为 1.01 美元,超过预期的 85 美分。同行业的 Conagra Brands 也在上个月公布了乐观的季度业绩,这得益于其主食和冷冻食品需求的反弹 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE0002141913.USD","IE00B2B36J28.USD","CAG","K","BK4588","MORN","BK4524","LU1571399168.USD","BK4532","BK4212","BK4504","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4585","LU1878469433.USD","BK4112","LU2065731478.USD","NVS","BK4578","IE00BJT1NW94.SGD","BK4007","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2431594928","title":"受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2431594928","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431594928?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:21","pubTimestamp":1714393287,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周一,德国生物技术公司Morphosys股价下滑,受到一则关于其药物或具有安全风险的新闻报道影响,但Morphosys表示,诺华制药对其收购仍有望在今年上半年完成。Pelabresib被视为Morphosys公司最有前途的药物之一,也是诺华制药对该公司感兴趣的原因之一。Morphosys发言人补充道:“诺华的收购计划正在稳步推进。”诺华制药于今年2月达成协议,将以27亿欧元的价格收购Morphosys公司。截至发稿,Morphosys美股盘前下跌2.38%,诺华制药美股盘前上涨了0.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4532","BK4585","IE0009355771.USD","IE0002141913.USD","BK1191","IE00B2B36J28.USD","01477","BK4139","NVS","LU0211331839.USD","IE00BFTCPJ56.SGD","MOR","BK4578","IE00BJT1NW94.SGD","BK4588","BK1574","BK4007","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2430261584","title":"诺华制药2024财年第一财季实现净利润26.88亿美元,同比增加17.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430261584","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430261584?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:09","pubTimestamp":1714028954,"startTime":"0","endTime":"0","summary":"3月31日,诺华制药公布财报,公告显示公司2024财年第一财季净利润为26.88亿美元,同比增加17.23%;其中营业收入为118.29亿美元,同比减少8.68%,每股基本收益为1.32美元。从资产负债表来看,诺华制药总负债545.78亿美元,其中短期债务85.64亿美元,资产负债比为1.73,流动比率为0.91。机构评级:截至2024年3月31日,当前有19家机构对诺华制药目标价做出预测,其中目标均价为110.01美元,其中最低目标价为81.24美元,最高目标价为130.70美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042515092587adf730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042515092587adf730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVS"],"gpt_icon":0},{"id":"2429312288","title":"隔夜美股全复盘(4.24)| 三大股指集体高收,英伟达涨近4%;特斯拉营收遇滑铁卢,意外宣布力推平价车型助推股价盘后一度涨逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429312288","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429312288?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:02","pubTimestamp":1713916943,"startTime":"0","endTime":"0","summary":"三大股指集体高收,英伟达涨近4%;特斯拉营收遇滑铁卢,意外宣布力推平价车型助推股价盘后一度涨逾11%","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/723110","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["SHEL","AAPL","GE","SAP","SSNLF","MU","ASML","TSLA","NVS","PEP","SPOT","NVDA","META","TAN","UPS","TSLL","MSFT"],"gpt_icon":1},{"id":"2429411083","title":"欧股“十一罗汉”|AI云概念股SAP收涨将近5.3%,阿斯麦控股涨2.6%,诺和诺德与诺华涨超1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429411083","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429411083?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:41","pubTimestamp":1713890504,"startTime":"0","endTime":"0","summary":"思爱普收涨5.27%,报174.860欧元,连续第二个交易日反弹,3月27日曾涨至184.48欧元创盘中历史最高。阿斯麦控股荷兰阿姆斯特丹股价收涨2.59%,报834.30欧元。诺和诺德哥本哈根股价收涨1.83%,报891.30。诺华制药收涨1.81%,罗氏控股收涨1.73%,LVMH集团收涨1.31%,赛诺菲收涨0.77%,葛兰素史克伦敦股价收涨0.70%,雀巢收涨0.45%,阿斯利康收涨0.16%,欧莱雅收跌0.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042400414587a6f2aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042400414587a6f2aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2063271972.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0097036916.USD","BK4585","BK4147","NVS","IE00BJJMRZ35.SGD","BK4007","IE0004445239.USD","03165","LU0211331839.USD","BK4578","BK4588","SAP","BK4532","NVO","ASML","BK4528","IE0009355771.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00BD6J9T35.USD","BK4023"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novartis.com","stockEarnings":[{"period":"1week","weight":-0.0499},{"period":"1month","weight":0.0113},{"period":"3month","weight":0.1247},{"period":"6month","weight":-0.0194},{"period":"1year","weight":0.0095},{"period":"ytd","weight":0.0511}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novartis AG于1996年2月29日在瑞士成立。该公司提供满足全球患者和社会不断变化的需求的医疗保健解决方案。他们广泛的产品组合包括创新药物和肿瘤药物,仿制药和生物仿制药以及眼科护理设备。他们的使命是发现改善和延伸人们生活的新方法。他们的愿景是成为改变医学实践的值得信赖的领导者。他们的战略是利用科学的创新在不断增长的医疗领域提供更好的患者结果。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.014981},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.012188},{"month":3,"riseRate":0.5,"avgChangeRate":0.000575},{"month":4,"riseRate":0.708333,"avgChangeRate":0.018746},{"month":5,"riseRate":0.666667,"avgChangeRate":0.008804},{"month":6,"riseRate":0.56,"avgChangeRate":0.010664},{"month":7,"riseRate":0.68,"avgChangeRate":0.012257},{"month":8,"riseRate":0.375,"avgChangeRate":-0.006962},{"month":9,"riseRate":0.708333,"avgChangeRate":0.011946},{"month":10,"riseRate":0.458333,"avgChangeRate":-0.010373},{"month":11,"riseRate":0.625,"avgChangeRate":0.016564},{"month":12,"riseRate":0.708333,"avgChangeRate":0.0233}],"exchange":"NYSE","name":"诺华","nameEN":"Novartis AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺华,NVS,诺华股票,诺华股票老虎,诺华股票老虎国际,诺华行情,诺华股票行情,诺华股价,诺华股市,诺华股票价格,诺华股票交易,诺华股票购买,诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}